Duality Advisers, LP Medpace Holdings, Inc. Transaction History

Duality Advisers, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$284.87 - $413.31 $3,133 - $4,546	11 Added 0.17%	6,624 $2.68 Million
Q4 2023 Feb 01, 2024	BUY	$227.52 - $312.68 $1.31 Million - $1.8 Million	5,768 Added 682.6%	6,613 $2.03 Million
Q3 2023 Nov 02, 2023	SELL	$233.98 - $281.67 $1.61 Million - $1.94 Million	-6,896 Reduced 89.08%	845 $204,000
Q2 2023 Jul 31, 2023	BUY	$187.26 - $240.17 $725,819 - $930,898	3,876 Added 100.28%	7,741 $1.86 Million
Q1 2023 Jun 27, 2023	SELL	$174.31 - $239.52 $1.07 Million - $1.46 Million	-6,112 Reduced 61.26%	3,865 $726,000
Q4 2022 Feb 07, 2023	BUY	$153.06 - $226.57 $1.53 Million - $2.26 Million	9,977 New	9,977 $2.12 Million
Q2 2022 Aug 08, 2022	BUY	$130.2 - $168.03 $674,305 - $870,227	5,179 New	5,179 $775,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $9.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.